Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Role of parathyroid hormone in the glucose intolerance of chronic renal failure.
M Akmal, … , A Weisz, R A DeFronzo
M Akmal, … , A Weisz, R A DeFronzo
Published March 1, 1985
Citation Information: J Clin Invest. 1985;75(3):1037-1044. https://doi.org/10.1172/JCI111765.
View: Text | PDF
Research Article Article has an altmetric score of 3

Role of parathyroid hormone in the glucose intolerance of chronic renal failure.

  • Text
  • PDF
Abstract

Evidence has accumulated suggesting that the state of secondary hyperparathyroidism and the elevated blood levels of parathyroid hormone (PTH) in uremia participate in the genesis of many uremic manifestations. The present study examined the role of PTH in glucose intolerance of chronic renal failure (CRF). Intravenous glucose tolerance tests (IVGTT) and euglycemic and hyperglycemic clamp studies were performed in dogs with CRF with (NPX) and without parathyroid glands (NPX-PTX). There were no significant differences among the plasma concentrations of electrolytes, degree of CRF, and its duration. The serum levels of PTH were elevated in NPX and undetectable in NPX-PTX. The NPX dogs displayed glucose intolerance after CRF and blood glucose concentrations during IVGTT were significantly (P less than 0.01) higher than corresponding values before CRF. In contrast, blood glucose levels after IVGTT in NPX-PTX before and after CRF were not different. K-g rate fell after CRF from 2.86 +/- 0.48 to 1.23 +/- 0.18%/min (P less than 0.01) in NPX but remained unchanged in NPX-PTX (from 2.41 +/- 0.43 to 2.86 +/- 0.86%/min) dogs. Blood insulin levels after IVGTT in NPX-PTX were more than twice higher than in NPX animals (P less than 0.01) and for any given level of blood glucose concentration, the insulin levels were higher in NPX-PTX than NPX dogs. Clamp studies showed that the total amount of glucose utilized was significantly lower (P less than 0.025) in NPX (6.64 +/- 1.13 mg/kg X min) than in NPX-PTX (10.74 +/- 1.1 mg/kg X min) dogs. The early, late, and total insulin responses were significantly (P less than 0.025) greater in the NPX-PTX than NPX animals. The values for the total response were 143 +/- 28 vs. 71 +/- 10 microU/ml, P less than 0.01. There was no significant difference in the ratio of glucose metabolized to the total insulin response, a measure of tissue sensitivity to insulin, between the two groups. The glucose metabolized to total insulin response ratio in NPX (5.12 +/- 0.76 mg/kg X min per microU/ml) and NPX-PTX (5.18 +/- 0.57 mg/kg X min per microU/ml) dogs was not different but significantly (P less than 0.01) lower than in normal animals (9.98 +/- 1.26 mg/kg X min per microU/ml). The metabolic clearance rate of insulin was significantly (P less than 0.02) reduced in both NPX (12.1 +/- 0.7 ml/kg X min) and NPX-PTX (12.1 +/- 0.9 ml/kg X min) dogs, as compared with normal animals (17.4 +/- 1.8 ml/kg X min). The basal hepatic glucose production was similar in both groups of animals and nor different from normal dogs; both the time course and the magnitude of suppression of hepatic glucose production by insulin were similar in both in groups. There were no differences in the binding affinity, binding sites concentration, and binding capacity of monocytes to insulin among NPX, NPX-PTX, and normal dogs. The data show that (a) glucose intolerance does not develop with CRF in the absence of PTH, (b) PTH does not affect metabolic clearance of insulin or tissue resistance to insulin in CRF, and (c) the normalization of metabolism in CRF in the absence of PTH is due to increased insulin secretion. The results indicate that excess PTH in CRF interferes with the ability of the beta-cells to augment insulin secretion appropriately in response to the insulin-resistant state.

Authors

M Akmal, S G Massry, D A Goldstein, P Fanti, A Weisz, R A DeFronzo

×

Total citations by year

Year: 2021 2020 2018 2017 2016 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1981 1979 Total
Citations: 1 1 1 3 1 2 5 4 4 2 5 5 3 1 3 2 1 3 3 3 3 6 1 3 5 5 5 2 2 3 1 1 1 1 1 93
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (93)

Title and authors Publication Year
A history of uremic toxicity and of the European Uremic Toxin Work Group (EUTox)
R Vanholder, A Argiles, J Jankowski
Clinical Kidney Journal 2021
Parathyroid Glands in Chronic Kidney Disease
A Covic, D Goldsmith, PA Torres
2020
Diabetes Complications, Comorbidities and Related Disorders
E Bonora, R DeFronzo
2018
The potential role of the osteopontin–osteocalcin–osteoprotegerin triad in the pathogenesis of prediabetes in humans
G Daniele, D Winnier, A Mari, J Bruder, M Fourcaudot, Z Pengou, A Hansis-Diarte, C Jenkinson, D Tripathy, F Folli
Acta Diabetologica 2017
The incidence of new onset diabetes after transplantation and related factors: Single center experience
A Sinangil, V Celik, S Barlas, Y Koc, T Basturk, T Sakaci, EB Akin, T Ecder
Nefrología (English Edition) 2017
Current therapeutic approaches in the management of hyperglycemia in chronic renal disease
V Garla, L Yanes-Cardozo, LF Lien
Reviews in Endocrine and Metabolic Disorders 2017
Parathyroid hormone induces adipocyte lipolysis via PKA-mediated phosphorylation of hormone-sensitive lipase
S Larsson, HA Jones, O Göransson, E Degerman, C Holm
Cellular Signalling 2016
Glycemic Management in ESRD and Earlier Stages of CKD
ME Williams, R Garg
American Journal of Kidney Diseases 2014
Hyperparathyroidism and New Onset Diabetes After Renal Transplantation
KM Ivarsson, N Clyne, M Almquist, S Akaberi
Transplantation Proceedings 2014
Nutritional Management of Renal Disease
A Molfino, BR Don, GA Kaysen
Nutritional Management of Renal Disease 2013
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich
Seldin and Giebisch's The Kidney 2013
Diabetes Management in the Kidney Patient
R Garg, ME Williams
Medical Clinics of North America 2013
Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism
TA Ikizler, NJ Cano, H Franch, D Fouque, J Himmelfarb, K Kalantar-Zadeh, MK Kuhlmann, P Stenvinkel, P TerWee, D Teta, AY Wang, C Wanner
Kidney International 2013
Loss of Amino Acids Into Dialysate During Hemodialysis Using Hydrophilic and Nonhydrophilic Polyester-Polymer Alloy and Polyacrylonitrile Membrane Dialyzers: AA Losses Using PEPA and PAN Membranes
A Yokomatsu, T Fujikawa, Y Toya, M Shino-Kakimoto, Y Itoh, H Mitsuhashi, K Tamura, N Hirawa, G Yasuda, S Umemura
Therapeutic Apheresis and Dialysis 2013
Insulin Resistance in Patients with Chronic Kidney Disease
MT Liao, CC Sung, KC Hung, CC Wu, L Lo, KC Lu
Journal of Biomedicine and Biotechnology 2012
Secondary Hyperparathyroidism : Benign Bystander or Culpable Contributor to Adverse Health Outcomes?
AN Peiris, D Youssef, WB Grant
Southern Medical Journal 2012
Glycemic Control in Diabetic Dialysis Patients and the Burnt-Out Diabetes Phenomenon
J Park, P Lertdumrongluk, MZ Molnar, CP Kovesdy, K Kalantar-Zadeh
Current Diabetes Reports 2012
Pathophysiology of the aging kidney and therapeutic interventions
K Kanasaki, M Kitada, D Koya
Hypertension Research 2012
Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease
A Lishmanov, S Dorairajan, Y Pak, K Chaudhary, A Chockalingam
International Urology and Nephrology 2011
Severe hypoglycemia with endogenous hyperinsulinemia in a nondiabetic hemodialysis patient following parathyroidectomy
R Nikalji, JM Bargman
Nephrology Dialysis Transplantation 2011
Sequence of Cellular Events in Pancreatic Islets Leading to Impaired Insulin Secretion in Chronic Kidney Disease
SG Massry
Journal of Renal Nutrition 2011
Predicting hospital cost in CKD patients through blood chemistry values
RW Bessette, RL Carter
BMC Nephrology 2011
Glycemic Control and Burnt-Out Diabetes in ESRD
CP Kovesdy, JC Park, K Kalantar-Zadeh
Seminars in Dialysis 2010
Glycated haemoglobin and the incidence of end-stage renal disease in diabetics
SW Oh, YC Kim, HS Koo, DC Jin, KY Na, DW Chae, S Kim, HJ Chin
Nephrology Dialysis Transplantation 2010
Parathyroid hormone suppresses insulin signaling in adipocytes
E Chang, SS Donkin, D Teegarden
Molecular and Cellular Endocrinology 2009
Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus
K Kalantar-Zadeh, SF Derose, S Nicholas, D Benner, K Sharma, CP Kovesdy
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2009
Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism
F Tassone, M Procopio, L Gianotti, G Visconti, A Pia, M Terzolo, G Borretta
Diabetic Medicine 2009
Insulin Resistance in Chronic Uremia
G Guarnieri, M Zanetti, P Vinci, MR Cattin, R Barazzoni
Journal of Renal Nutrition 2009
Insulino résistance et inflammation en insuffisance rénale
F Guebre-Egziabher, E Kalbacher, D Fouque
Néphrologie & Thérapeutique 2009
Modern Nutrition
K LaPoint, M McIntosh
Handbook of Nutrition in the Aged, Fourth Edition 2008
Glycemic Control in Diabetic CKD Patients: Where Do We Stand?
CP Kovesdy, K Sharma, K Kalantar-Zadeh
American Journal of Kidney Diseases 2008
NON-CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Cardiac Problems in the Dialysis Patient: Beyond Coronary Disease
A Remppis, E Ritz
Seminars in Dialysis 2008
Inflammation and Insulin Resistance in Uremia
M Zanetti, R Barazzoni, G Guarnieri
Journal of Renal Nutrition 2008
Parathyroid Hormone: Effects on Glucose Homeostasis and Insulin Sensitivity in Chronic Renal Failure Patients on Regular Hemodialysis
NA Ahamed, MY Abdul-Aziz, AA El-Bauomy, TS Salem
Journal of Taibah University Medical Sciences 2008
Insulin and its role in chronic kidney disease
RH Mak
Pediatric Nephrology 2007
The effect of dialysis membrane flux on amino acid loss in hemodialysis patients
HW Gil, JO Yang, EY Lee, EM Lee, JS Choi, SY Hong
Journal of Korean Medical Science 2007
Alanine to Serine Polymorphism at Position 986 of the Calcium-Sensing Receptor Associated with Coronary Heart Disease, Myocardial Infarction, All-Cause, and Cardiovascular Mortality
W März, U Seelhorst, B Wellnitz, B Tiran, B Obermayer-Pietsch, W Renner, BO Boehm, E Ritz, MM Hoffmann
The Journal of clinical endocrinology and metabolism 2007
Influence of the parathyroid glands on bone metabolism
HH Malluche, N Koszewski, MC Monier-Faugere, JP Williams, H Mawad
European Journal of Clinical Investigation 2006
Parathyroid Hormone Levels, Calcium-Channel Blockers, and the Dyslipidemia of Nondiabetic Hemodialysis Patients
S Zanos, E Mitsopoulos, G Sakellariou
Renal Failure 2005
Nutraceutical resources for diabetes prevention – an update
MF McCarty
Medical Hypotheses 2005
Low 25-Hydroxyvitamin D Does Not Affect Insulin Sensitivity in Obesity after Bariatric Surgery
M Manco, M Calvani, G Nanni, AV Greco, A Iaconelli, G Gasbarrini, M Castagneto, G Mingrone
Obesity research 2005
Derangement of glucose metabolism in hyperparathyroidism
M Procopio, G Borretta
Journal of Endocrinological Investigation 2003
Treatment of Insulin Resistance in Uremia
V Stefanović, V Nešić, B Stojimirović
The International Journal of Artificial Organs 2003
Calcium in Internal Medicine
H Morii, Y Nishizawa, SG Massry
2002
Insulin secretion in uremia
SG Massry
American Journal of Kidney Diseases 2001
Lipid Metabolism and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Role of Factors Modulating Cytosolic Calcium
MF Gadallah, M El-Shahawy, G Andrews, C Torres-Rivera, D Hanna, M Blatt, M Ibrahim, A Morkos, M Abbassian, M Cooper
Hemodialysis International 2001
Association of Hypertriglyceridemia and Insulin Resistance in UREMIC Patients Undergoing CAPD
SC Cheng, TS Chu, KY Huang, YM Chen, WK Chang, TJ Tsai, KD Wu
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2001
Impact of End-Stage Renal Disease and Dialysis on Glycemic Control
RH Mak
Seminars in Dialysis 2000
Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level
KC Chiu, LM Chuang, NP Lee, JM Ryu, JL McGullam, GP Tsai, MF Saad
Metabolism 2000
Nutritional status of hemodialysis patients with secondary hyperparathyroidism
LT Rezende, L Cuppari, AB Carvalho, ME Canziani, SR Manfredi, M Cendoroglo, DM Sigulem, SA Draibe
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.] 2000
Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure
SG Rostand, TB Drueke
Kidney International 1999
Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: Anabolic effect and functional improvement
G Johannsson, BÅ Bengtsson, J Ahlmén
American Journal of Kidney Diseases 1999
Intradialytic Parenteral Nutrition in Malnourished Hemodialysis Patients: A Prospective Long-Term Study
AK Mortelmans, P Duym, J Vandenbroucke, RD Smet, A Dhondt, G Lesaffer, HV Ir, R Vanholder
JPEN. Journal of parenteral and enteral nutrition 1999
Effects of parathyroid hormone infusion on glucose tolerance and glucose-stimulated insulin secretion in normal and uremic rats
S Chen
Diabetes Research and Clinical Practice 1998
Effects of low-protein diet on carbohydrate metabolism and energy expenditure
V Rigalleau, M Aparicio, H Gin
Journal of Renal Nutrition 1998
Critical Care Nephrology
C Ronco, R Bellomo
1998
Altered Muscle Energy Metabolism in Post-absorptive Patients with Chronic Renal Failure
O Pastoris, R Aquilani, P Foppa, G Bovio, S Segagni, P Baiardi, M Catapano, M Maccario, A Salvadeo, M Dossena
Scandinavian Journal of Urology and Nephrology 1997
Effects of excess PTH on nonclassical target organs
S Bro, K Olgaard
American Journal of Kidney Diseases 1997
The role of abdominal adiposity and insulin resistance in dyslipidemia of chronic renal failure
P Lee, D O'Neal, B Murphy, J Best
American Journal of Kidney Diseases 1997
Cardiovascular risk factors in patients with chronic renal failure
DC Wheeler
Journal of Renal Nutrition 1997
Pathogenesis of dyslipoproteinemia in renal insufficiency: the role of lipoprotein lipase and hepatic lipase
M Árnadóttir
Scandinavian Journal of Clinical & Laboratory Investigation 1997
La Tolleranza Glicidica Nell'insufficienza Renale Cronica
AM Ciciani, F Bergesio, G Monzani, R Ciuti, F Martinelli, R Piperno, G Baldereschi, M Salvadori
1997
Effect of recombinant human erythropoietin on insulin, amino acid, and lipid metabolism in uremia
RH Mak
The Journal of Pediatrics 1996
Intravenous calcitriol normalizes insulin sensitivity in uremic patients
A Kautzky-Willer, G Pacini, U Barnas, B Ludvik, C Streli, H Graf, R Prager
Kidney International 1995
The role of the parathyroid glands in the uremic syndrome
E Ritz, A Stefanski, M Rambausek
American Journal of Kidney Diseases 1995
Excess PTH in CRF induces pulmonary calcification, pulmonary hypertension and right ventricular hypertrophy
M Akmal, RR Barndt, AN Ansari, JG Mohler, SG Massry
Kidney International 1995
Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion
B Ludvik, M Clodi, A Kautzky-Willer, M Schuller, H Graf, E Hartter, G Pacini, R Prager
Journal of Clinical Investigation 1994
Amino acid and albumin losses during hemodialysis
TA Ikizler, PJ Flakoll, RA Parker, RM Hakim
Kidney International 1994
Short-term effects of recombinant human growth hormone in CAPD patients
TA Ikizler, RL Wingard, JA Breyer, G Schulman, RA Parker, RM Hakim
Kidney International 1994
Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism
S Kumar, AO Olukoga, C Gordon, EB Mawer, M France, JP Hosker, M Davies, AJ Boulton
Clinical Endocrinology 1994
Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D
S Kumar, M Davies, Y Zakaria, EB Mawer, C Gordon, AO Olukoga, AJ Boulton
Postgraduate medical journal 1994
Glucose Metabolism in Chronic Renal Failure with Reference to GH Treatment of Uremic Children
O Schmitz, L Ørskov, S Lund, N Møller, JS Christiansen, H Ørskov
Journal of Pediatric Endocrinology and Metabolism 1993
Selective parathyroidectomy of the dog
DR Finco, SA Brown, DC Ferguson, WA Crowell
Canadian journal of veterinary research = Revue canadienne de recherche vétérinaire 1993
The Effects of Recombinant Human Growth Hormone and Intradialytic Parenteral Nutrition in Malnourished Hemodialysis Patients
G Schulman, RL Wingard, RL Hutchison, P Lawrence, RM Hakim
American Journal of Kidney Diseases 1993
The Effects of Various Antihypertensive Agents on Cardiovascular Risk Factors in Patients With Renal Failure
M Zarama, L Raij
American Journal of Kidney Diseases 1993
Malnutrition in Hemodialysis Patients
RM Hakim, N Levin
American Journal of Kidney Diseases 1993
The Role of Parathyroid Hormone as a Uremic Toxin: Current Concepts
DA Feinfeld
Seminars in Dialysis 1992
Hyperphosphatemia: Its Consequences and Treatment in Patients With Chronic Renal Disease
JA Delmez, E Slatopolsky
American Journal of Kidney Diseases 1992
Cardiovascular Risk Factors in Chronic Renal Failure and Hemodialysis Populations
KW Ma, EL Greene, L Raij
American Journal of Kidney Diseases 1992
Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients
RH Mak
Kidney International 1992
Effects of 1,25 (OH) 2 D 3 Treatment on Lipid Levels in Uremic Hemodialysis Patients
M Yeksan, S Türk, M Polat, A Çiǧli, Y Erdoǧan
The International Journal of Artificial Organs 1992
On the mechanism of impaired insulin secretion in chronic renal failure
GZ Fadda, SM Hajjar, AF Perna, XJ Zhou, LG Lipson, SG Massry
Journal of Clinical Investigation 1991
Impaired insulin secretion of aging: Role of renal failure and hyperparathyroidism
SG Massry, GZ Fadda, XJ Zhou, P Chandrasoma, L Cheng, CR Filburn
Kidney International 1991
Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure
M Akmal, SE Kasim, AR Soliman, SG Massry
Kidney International 1990
Direct effect of parathyroid hormone on insulin secretion from pancreatic islets
GZ Fadda, M Akmal, LG Lipson, SG Massry
American journal of physiology. Endocrinology and metabolism 1990
Carbohydrate Metabolism in End-Stage Renal Disease
SK Mujais, G Fadda
Seminars in Dialysis 1989
Correction of glucose intolerance and the impaired insulin release of chronic renal failure by verapamil
GZ Fadda, M Akmal, AR Soliman, LG Lipson, SG Massry
Kidney International 1989
Carbohydrate metabolism in uremia
RH Mak
Pediatric Nephrology 1989
Insulin release from pancreatic islets: Effects of CRF and excess PTH
GZ Fadda, M Akmal, FH Premdas, LG Lipson, SG Massry
Kidney International 1988
Uremic Toxins
S Ringoir, R Vanholder, SG Massry
1987
Toxins and Inhibitors in Chronic Renal Failure
D Powell, J Bergstrom, R Dzurik, P Gulyassy, D Lockwood, L Phillips
American Journal of Kidney Diseases 1986
Contemporary Nephrology
S Klahr, SG Massry
1981
Replacement of Renal Function by Dialysis
W Drukker, FM Parsons, JF Maher
1979

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 clinical guideline sources
20 readers on Mendeley
See more details